Evidence map›Paper›PMID 25225613›Full record

ReviewThe EMBO journal2014

Scaling of immune responses against intracellular bacterial infection.

Zeinab Abdullah, Percy A Knolle

Abstract readReview
In one paragraph

Review in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. DNA PAMPs as Molecular Tools for the cGAS-STING Signaling Pathways.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  6. Biological Activities and Chemical Profiles ofPlants (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Duck Enteritis Virus VP16 Antagonizes IFN-Journal of immunology research · 2020
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Nanoparticle-based local antimicrobial drug delivery.Advanced drug delivery reviews · 2018
    Review
  16. Liver - guardian, modifier and target of sepsis.Nature reviews. Gastroenterology & hepatology · 2017
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zeinab AbdullahInstitutes of Molecular Medicine and Experimental Immunology, Universität Bonn, Bonn, Germany.
Percy A KnolleInstitutes of Molecular Medicine and Experimental Immunology, Universität Bonn, Bonn, Germany Institute of Molecular Immunology (IMI), Technische Universität München, München, Germany percy.knolle@tum.de.
University of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages detect bacterial infection through pattern recognition receptors (PRRs) localized at the cell surface, in intracellular vesicles or in the cytosol. Discrimination of viable and virulent bacteria from non-virulent bacteria (dead or viable) is necessary to appropriately scale the anti-bacterial immune response. Such scaling of anti-bacterial immunity is necessary to control the infection, but also to avoid immunopathology or bacterial persistence. PRR-mediated detection of bacterial constituents in the cytosol rather than at the cell surface along with cytosolic recognition of secreted bacterial nucleic acids indicates viability and virulence of infecting bacteria. The effector responses triggered by activation of cytosolic PRRs, in particular the RIG-I-induced simultaneous rapid type I IFN induction and inflammasome activation, are crucial for timely control of bacterial infection by innate and adaptive immunity. The knowledge on the PRRs and the effector responses relevant for control of infection with intracellular bacteria will help to develop strategies to overcome chronic infection.

Indexed as

Adaptive ImmunityBacterial InfectionsCytosolDNA, BacterialImmunity, InnateInterferon Type IMacrophagesReceptors, Pattern RecognitionRNA, BacterialSignal TransductionDNA, BacterialInterferon Type IReceptors, Pattern RecognitionRNA, Bacterialcytosolic pattern recognition receptorsinterferonRIG‐I inflammasome activationsecreted bacterial nucleic acids

Identifiers

PMID25225613
PMCPMC4253520
OpenAlexW2133480107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.